Treatment of hypertrophic cardiomyopathy caused by cardiospecific variants of Fabry disease with chaperone therapy

Eur Heart J. 2018 May 21;39(20):1861-1862. doi: 10.1093/eurheartj/ehy072.
No abstract available

Publication types

  • Case Reports
  • Video-Audio Media

MeSH terms

  • 1-Deoxynojirimycin / analogs & derivatives
  • 1-Deoxynojirimycin / therapeutic use
  • Cardiomyopathy, Hypertrophic / diagnostic imaging
  • Cardiomyopathy, Hypertrophic / drug therapy*
  • Cardiomyopathy, Hypertrophic / etiology*
  • Echocardiography
  • Electrocardiography
  • Fabry Disease / complications*
  • Fabry Disease / diagnostic imaging
  • Fabry Disease / drug therapy
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Molecular Chaperones / therapeutic use

Substances

  • Molecular Chaperones
  • 1-Deoxynojirimycin
  • migalastat